Sanofi-Aventis SA and Merck & Co. plan to sell animal-health assets valued at about $1 billion after agreeing to combine their veterinary-medicine businesses this year.
Morgan Stanley, which is advising on the sale, sent out documents to prospective buyers, which may include Pfizer Inc., Bayer AG, Boehringer Ingelheim GmbH, Eli Lilly & Co. and Novartis AG, according to sources who declined to be identified because the matter isn’t public.
World’s largest animal-health business/ billions in sales
The combined venture, which creates the world’s largest animal-health business, will have annual sales of about $5.3 billion before any divestments, Chris Viehbacher, Sanofi’s chief executive officer said in a Sept. 15 presentation to investors.